Remove 2022 Remove Drug Development Remove Packaging
article thumbnail

STAT+: How much more are health care’s bosses making than their employees?

STAT

How much health care’s bigwigs are making Mike Reddy for STAT Health care stocks lagged behind the broader market in 2023, and that was reflected in many CEO pay packages. billion combined last year , compared with $4 billion in 2022. million in 2022. Those figures compared to an average of $13 million and median of $4.3

Packaging 222
article thumbnail

European Pharmaceutical Review Issue 6 2022

European Pharmaceutical Review

Patient-centred pharmaceutical packaging: are we there yet? DRUG DEVELOPMENT. The post <em>European Pharmaceutical Review </em> Issue 6 2022 appeared first on European Pharmaceutical Review. Arnaud Robert and Brendan O’Callaghan, Sanofi. Giana Carli Lorenzini, Technical University of Denmark.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more

STAT

Hope you have a meaningful and productive day and, of course, do stay in touch… Congress has abandoned its attempt to reform how pharmacy middlemen operate in an upcoming package to fund the federal government , STAT reports. Drug makers and pharmacy benefit managers have fought a very public battle on the airwaves.

Packaging 212
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. Key areas of potential legislative change. Future outlook.

article thumbnail

Responsible sourcing and manufacturing: Growing towards a sustainable future with Lonza

Express Pharma

Carbon contributing factors: The mitigating factors throughout the drug development process The carbon-contributing factors in the production and distribution of Capsugel capsules at Lonza can be categorised into three main areas: upstream, operational, and downstream activities.

Dosage 104
article thumbnail

Develop and execute a winning drug launch strategy with an experienced contract packager

Pharmaceutical Technology

Navigating the complexities of pharma and biotech packaging services can be difficult. With the growing number of complex therapies that require specialized packaging and handling requirements, selecting the right contract packaging organization (CPO) involves evaluating what services and additional benefits they can bring to your business.

article thumbnail

Pre-Filled Syringes San Francisco Conference 2022

pharmaphorum

September 19 – 20, 2022 | San Francisco, CA, USA. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. Who should attend: Drug-delivery developers.